INMED PHARMACEUTICALS INC. (INM) Operating cash flow 2020–2026
INMED PHARMACEUTICALS INC. (INM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$8.6MFY2026 · since FY2020: -$7.4M → -$8.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$8.6M | -6.7% |
| FY2025 | -$8.1M | -15.9% |
| FY2024 | -$7.0M | +4.1% |
| FY2023 | -$7.3M | +53.3% |
| FY2022 | -$15.6M | -59.2% |
| FY2021 | -$9.8M | -32.8% |
| FY2020 | -$7.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice